ARTICLE | Company News
MorphoSys, Boehringer Ingelheim deal
July 14, 2008 7:00 AM UTC
Boehringer exercised an option to acquire a non-exclusive license to use MorphoSys’ RapMAT technology for antibody optimization under a 2003 deal that was expanded in 2005. Boehringer also has a licen...